Cell Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Cell Therapy Technologies Market Report is Segmented by Type (Autologous and Allogeneic), Therapy (Mesenchymal Stem Cell Therapy, Fibroblast Cell Therapy, Hematopoietic Stem Cell Therapy, and Other Therapies), Application (Musculoskeletal, Malignancies, Cardiovascular, Dermatology and Wounds, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).

Cell Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

Cell Therapy Market Size

Cell Therapy Market Summary
Study Period 2021 - 2030
Base Year For Estimation 2024
Market Size (2025) USD 5.58 Billion
Market Size (2030) USD 12.27 Billion
CAGR (2025 - 2030) 17.05 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

Cell Therapy Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Cell Therapy Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Cell Therapy Market Analysis

The Cell Therapy Market size is estimated at USD 5.58 billion in 2025, and is expected to reach USD 12.27 billion by 2030, at a CAGR of 17.05% during the forecast period (2025-2030).

The cell therapy market is anticipated to experience significant growth driven by the growing incidence of chronic diseases, a growing acceptance of regenerative medicine, and an increase in clinical research focused on cellular therapy advancements.

The rising burden of chronic diseases and other health conditions across the world fuels the need for cell therapy, thus driving the growth of the cell therapy market. For instance, in June 2023, as per the Institute for Health Metrics and Evaluation, approximately 500 million adults around the world were diagnosed with diabetes, and this figure is projected to rise to 1.3 billion by 2050. Additionally, the data published by the World Health Organization in February 2024 mentioned that it is anticipated that there will be over 35 million new cancer cases, which represents a 77% rise from the estimated 20 million cases in 2022 globally. As a result, the rising prevalence of chronic conditions fuels the demand for different cell therapies in their treatment and is expected to drive growth in the cell therapy industry.

Furthermore, product approvals, collaborations, and a rise in clinical studies focused on the development of cellular therapies are expected to propel the cell therapy market's growth during the forecast period. For instance, in October 2023, Caribou Biosciences Inc. obtained approval from the Food and Drug Administration (FDA) for an investigational new drug application for an allogeneic cell therapy, anti-CLL-1 chimeric antigen receptor (CAR) T cell therapy CB-012 indicated for the treatment of patients with relapsed/refractory acute myeloid leukemia (AML). Moreover, in April 2023, Seattle Children's Therapeutics introduced a first-in-human phase-1 clinical trial, BrainChild-04, a chimeric antigen receptor (CAR) T-cell clinical trial targeting four antigens at the same time to address the needs of children, teens, and young adults with diffuse intrinsic pontine glioma (DIPG), diffuse midline glioma (DMG), and other brain and spinal cord tumors. Hence, such developments associated with cell therapies are likely to increase product availability and competition, reflecting the current cell therapy market trends, which contributes to the market's growth during the forecast period.

Thus, the rising burden of chronic diseases and increasing product approvals and clinical trials are expected to positively influence the cell therapy market growth during the forecast period. However, the high cost associated with cell therapies is expected to hinder the growth of the cell therapy market.

Cell Therapy Industry Overview

The cell therapy market is moderately competitive, with the presence of a considerable number of cell therapy companies. The major companies in the cell therapy industry are evolving through various strategies such as investment in research and development, acquisitions, partnerships, and collaborations to secure their market positions. The major companies in the market are Corestem Inc., Chiesi Farmaceutici SpA, Tegoscience, and Takeda Pharmaceuticals.

Cell Therapy Market Leaders

  1. Corestem Inc.

  2. Chiesi Farmaceutici S.p.A.

  3. Tego Science

  4. Allogene Therapeutics Inc.

  5. Takeda Pharmaceuticals

  6. *Disclaimer: Major Players sorted in no particular order
Cell Therapy Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Cell Therapy Market News

  • August 2024: Adaptimmune Therapeutics PLC was granted approval by the US FDA for TECELRA (afamitresgene autoleucel), marking it as the first engineered cell therapy approved for use in solid tumors and therapy for a rare, soft tissue cancer, synovial sarcoma.
  • January 2024: Abbvie and Umoja Biopharma established a strategic collaboration to develop various in-situ generated CAR-T cell therapy candidates in oncology by incorporating Umoja's proprietary VivoVec gene delivery platform.

Cell Therapy Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Prevalence of Chronic Conditions
    • 4.2.2 Rising Adoption of Regenerative Medicine
    • 4.2.3 Rise in Number of Clinical Studies Pertaining to the Development of Cellular Therapies
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Therapies
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 Type
    • 5.1.1 Autologous
    • 5.1.2 Allogeneic
  • 5.2 Therapy
    • 5.2.1 Mesenchymal Stem Cell Therapy
    • 5.2.2 Fibroblast Cell Therapy
    • 5.2.3 Hematopoietic Stem Cell Therapy
    • 5.2.4 Other Therapies
  • 5.3 Application
    • 5.3.1 Musculoskeletal
    • 5.3.2 Malignancies
    • 5.3.3 Cardiovascular
    • 5.3.4 Dermatology and Wounds
    • 5.3.5 Other Applications
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Tego Science
    • 6.1.2 Chiesi Farmaceutici SpA
    • 6.1.3 Corestem Inc.
    • 6.1.4 Nipro Corporation
    • 6.1.5 MEDIPOST Co. Ltd
    • 6.1.6 Takeda Pharmaceuticals
    • 6.1.7 Stempeutics Research Pvt. Ltd
    • 6.1.8 Gilead Sciences Inc. (Kite Pharma Inc.)
    • 6.1.9 Allogene Therapeutics Inc.
    • 6.1.10 Novartis AG
    • 6.1.11 Vericel Corporation
    • 6.1.12 Organogenesis Inc.
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers - Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Cell Therapy Industry Segmentation

As per the scope of the report, cell therapy is known as a type of therapy in which live cells are injected into a patient for the treatment of a number of disorders by replacing diseased or dysfunctional cells with healthy functioning ones. Some of the cells used for the treatment include hematopoietic (blood-forming) stem cells (HSC), skeletal muscle stem cells, mesenchymal stem cells, lymphocytes, dendritic cells, and pancreatic islet cells. 

The cell therapy market is segmented by type, therapy, application, and geography. By type, the market is segmented into autologous and allogeneic. By therapy, the market is segmented into mesenchymal stem cell therapy, fibroblast cell therapy, hematopoietic stem cell therapy, and other therapies. By application, the market is segmented into musculoskeletal, malignancies, cardiovascular, dermatology and wounds, and other applications. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America. The market size is provided for each segment in terms of value (USD).

Type Autologous
Allogeneic
Therapy Mesenchymal Stem Cell Therapy
Fibroblast Cell Therapy
Hematopoietic Stem Cell Therapy
Other Therapies
Application Musculoskeletal
Malignancies
Cardiovascular
Dermatology and Wounds
Other Applications
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Cell Therapy Market Research FAQs

How big is the Cell Therapy Market?

The Cell Therapy Market size is expected to reach USD 5.58 billion in 2025 and grow at a CAGR of 17.05% to reach USD 12.27 billion by 2030.

What is the current Cell Therapy Market size?

In 2025, the Cell Therapy Market size is expected to reach USD 5.58 billion.

Who are the key players in Cell Therapy Market?

Corestem Inc., Chiesi Farmaceutici S.p.A., Tego Science, Allogene Therapeutics Inc. and Takeda Pharmaceuticals are the major companies operating in the Cell Therapy Market.

Which is the fastest growing region in Cell Therapy Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Cell Therapy Market?

In 2025, the North America accounts for the largest market share in Cell Therapy Market.

What years does this Cell Therapy Market cover, and what was the market size in 2024?

In 2024, the Cell Therapy Market size was estimated at USD 4.63 billion. The report covers the Cell Therapy Market historical market size for years: 2021, 2022, 2023 and 2024. The report also forecasts the Cell Therapy Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Cell Therapy Industry Report

The report covers an extensive market analysis of the global cell therapy technologies market, highlighting significant trends and industry research. The market overview includes a detailed segmentation by type, therapy, application, and geography, offering a comprehensive market outlook. Industry reports indicate a positive market growth trajectory, driven by advancements in mesenchymal stem cell therapy, fibroblast cell therapy, and hematopoietic stem cell therapy.

The market forecast suggests promising market value and market size expansion across various regions, including North America, Europe, Asia-Pacific, the Middle East and Africa, and South America. The industry statistics reveal substantial growth in applications such as musculoskeletal, malignancies, cardiovascular, dermatology, and wounds.

Market leaders are leveraging these trends to enhance their market share and industry size. The market trends and market predictions point towards a robust growth rate, supported by extensive industry information and industry outlook.

This report example, available as a report PDF, provides crucial market data and market review for stakeholders. The market segmentation analysis underscores the diverse applications and therapies driving the industry's evolution. The research companies involved in this study offer valuable insights into the industry's future trajectory, making this an essential resource for understanding the global market dynamics.